Yubo Zhou

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Chinese Academy of Sciences, Zhejiang University, Suzhou Baijibugong Pharmaceutical Technology Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yubo Zhou. Retrieved from https://idiyas.com/inventor/yubo-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 88.9

CIPO Patents = 4

EPO Patents = 10 (Patent Applications = 18)

Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 10(Granted Patents)

Company Filing History:

14 out of 3,363

Chinese Academy of Sciences

Suzhou Baijibugong Pharmaceutical Technology Co., Ltd.

patents

4. 3 out of 3

Zibo Biopolar Changsheng Pharmaceutical Co. Ltd.

patents

5. 1 out of 2

Shanghai Puyi Chemical Co., Ltd.

patents

6. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase Inhibitors

Aromatic Ring-Pyrimidine Derivatives

Isoindoline Compounds

Aminoquinazolinone Derivatives

Cyclopropylamine Compounds

Heterocyclic Derivatives

Pharmaceutical Compositions

Antitumor Applications

Thiazole Compounds

Preparation Methods

Chemical Compounds

Nitrogen-Containing Compounds

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698277 - 2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof (2026-08-04),

2. 12459921 - Isoindoline compound, preparation method, pharmaceutical composition and use thereof (2025-11-04),

3. 12404269 - Aminoquinazolinone and aminoisoquinolinone derivatives and application thereof (2025-09-02),

4. 11974999 - Bruton's tyrosine kinase inhibitors (2024-05-07),

5. 11873292 - Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof (2024-01-16),

6. 11591325 - 2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof (2023-02-28),

7. 11554118 - Bruton's tyrosine kinase inhibitors (2023-01-17),

8. 10933063 - Bruton's tyrosine kinase inhibitors (2021-03-02),

9. 10836743 - Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof (2020-11-17),

10. 10822327 - 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof (2020-11-03),

11. 10793566 - Bruton's tyrosine kinase inhibitors (2020-10-06),

12. 10766889 - Aryl-2,2'-tandem bisthiazole compound and preparation method and use thereof (2020-09-08),

13. 10662187 - Bruton's tyrosine kinase inhibitors (2020-05-26),

14. 10358446 - Bruton's tyrosine kinase inhibitors (2019-07-23),

15. 10233180 - Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof (2019-03-19),

Title: Yubo Zhou - Pioneering Inventor from Shanghai

Introduction: Yubo Zhou is a distinguished inventor hailing from Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yubo Zhou holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Yubo Zhou has worked with leading tech companies in Shanghai, driving innovation and spearheading projects that have revolutionized the industry.

Collaborations: Throughout his career, Yubo Zhou has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge-sharing.

Conclusion: Yubo Zhou's passion for innovation, coupled with his relentless drive to push the boundaries of technology, cements his legacy as a visionary inventor shaping the future of the industry.

Profile summary based on public USPTO records.